CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- 4 Grant or award Controller acquired 3,250 shares (grant or award)
- 4 Open-market sale Director sold 5,631 shares at $24.02 ($135,228)
- 4 Open-market sale Director sold 94,251 shares at an average $24.16 ($2,276,684)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 51,785 shares at an average $17.60 ($911,416)
- 4 Open-market sale See Remarks sold 60,000 shares at an average $20.42 ($1,225,000)
Page 6 of 12 · 221 filings